⌂
Home
◈
Markets
▦
Screener
📈
Tools
◎
Portfolio
Skip to content
DFM General
5,734.19
−1.44%
FTSE ADX
9,588.41
−1.17%
TASI
9,695.86
−2.32%
QE Index
8,611.10
−0.37%
S&P 500
7,643.16
−0.26%
Nasdaq 100
29,080.20
+0.42%
Nifty 50
22,600.00
−0.39%
Sensex
73,123.83
−0.17%
KSE-100
162,374.88
−0.95%
DFM:EMIRATESNBD
AED 30.00
−3.47%
ADX:IHC
AED 350.00
−0.57%
SAU:2222
SAR 25.40
−0.70%
DSMD:QNBK
QAR 15.50
−1.02%
NAS:NVDA
$212.21
+0.00%
NYSE:TSM
$418.82
+1.57%
NSE:RELIANCE
₹1,190.00
+0.46%
KAR:OGDC
Rs 298.12
−0.79%
Gold
$4,000.33
−0.60%
Brent
$116.73
+3.40%
BTC
$81,632.84
+0.39%
ETH
$2,406.09
+0.84%
DFM General
5,734.19
−1.44%
FTSE ADX
9,588.41
−1.17%
TASI
9,695.86
−2.32%
QE Index
8,611.10
−0.37%
S&P 500
7,643.16
−0.26%
Nasdaq 100
29,080.20
+0.42%
Nifty 50
22,600.00
−0.39%
Sensex
73,123.83
−0.17%
KSE-100
162,374.88
−0.95%
DFM:EMIRATESNBD
AED 30.00
−3.47%
ADX:IHC
AED 350.00
−0.57%
SAU:2222
SAR 25.40
−0.70%
DSMD:QNBK
QAR 15.50
−1.02%
NAS:NVDA
$212.21
+0.00%
NYSE:TSM
$418.82
+1.57%
NSE:RELIANCE
₹1,190.00
+0.46%
KAR:OGDC
Rs 298.12
−0.79%
Gold
$4,000.33
−0.60%
Brent
$116.73
+3.40%
BTC
$81,632.84
+0.39%
ETH
$2,406.09
+0.84%
☰
Markets
▼
Stock markets
🇦🇪
UAE
DFM · ADX · DFM General
Closed
🇸🇦
Saudi Arabia
Tadawul · TASI
Closed
🇶🇦
Qatar
QSE · QE General
Closed
🇺🇸
United States
Nasdaq · NYSE · S&P 500
Open
🇮🇳
India
NSE · BSE · Nifty 50
Closed
🇵🇰
Pakistan
PSX · KSE-100
Closed
Other assets
₿
Crypto
Ranked by volume · 24/7
🥇
Gold, FX & economy
Dubai gold, AED crosses, rates
◫
ETFs
Index, sector and gold funds
Explore
▦
Market map
Every market as a heatmap
📅
Calendar & IPOs
Earnings, dividends, listings, releases
⌁
Options flow · Ownership · Politics
US filings and tapes
Screener
▼
⚲
Stock screener
All six markets, one row per company
★
Ready-made screens
Starting points with a point of view
📁
My saved screens
Saved rules with alerts on new matches
⇄
Compare
Up to five, side by side
Crypto
Tools
▼
📈
Charting
Drawings, indicators, replay
▶
Strategy Maker
Write a rule, test it on history
⇄
Compare
Side by side
🔔
Alerts
Price, earnings, screens, strategies
News
Portfolio
⌕
AED
USD
SAR
QAR
INR
PKR
GBP
EUR
KWD
OMR
BHD
☆
♢
☾
Sign in
Create account
👤
Scienture Holdings Inc · News · TradingHolo
Markets
›
United States
› NAS
› SCNX
S
Scienture Holdings Inc
NAS:SCNX
Healthcare
nasdaq_composite
$2.68
−3.25%
Live
In session · ≈
AED 9.84
· Market cap
$4.4M
· Next earnings
Thu 12 Nov
☆
Watch
🔔
Alert
⇄
Compare
▶
Test a strategy
✦
AI read
Overview
Chart
Financials
Valuation
Forecasts
Dividends
Ownership
Options
Shorts
News
Profile
SCNX news
Headlines tagged to this company
DO
Scienture Holdings Well Positioned to Deliver Continued Sequential Rev Growth >SCNX
Dow Jones Newswires · 28 h ago
DO
Scienture Holdings: Secures U.S. Patent Protection for REZENOPY Extending Into 2041 >SCNX
Dow Jones Newswires · 28 h ago
DO
Scienture Holdings 3Q Rev $1.22B >SCNX
Dow Jones Newswires · 28 h ago
GL
SCIENTURE Issues Shareholder Letter Highlighting Sequential Revenue Growth, Two FDA-Approved Commercial Products, and Continued Progress Toward Profitability in 2027
GlobeNewswire · 28 h ago
DO
Scienture Holdings Sees 3Q Rev $1.22M >SCNX
Dow Jones Newswires · 10 d ago
GL
SCIENTURE Reports Approximately $1.22 Million in Unaudited Preliminary Q3 2026 Revenue, Achieving 256% Sequential Growth
GlobeNewswire · 10 d ago
TR
Scienture Holdings, Inc. (SCNX) Wins 3 Pediatric Formulary Adds for Arbli
TradingView · 21 d ago
RE
Scienture Holdings Announces Reverse Stock Split
Reuters · 23 d ago
SE
Scienture announces 1-for-25 reverse stock split
Seeking Alpha · 23 d ago
SE
Scienture announces 1-for-25 reverse stock split
Seeking Alpha · 23 d ago
GL
Scienture Holdings, Inc. Announces Reverse Stock Split
GlobeNewswire · 23 d ago
GL
SCIENTURE Expands Commercial Reach of REZENOPY™ to Addiction Treatment Centers through an Agreement with a Distribution Partner
globenewswire · 31 d ago
GL
SCIENTURE to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14, 2026
globenewswire · 44 d ago
GL
SCIENTURE Reports Q2 2026 Results with Approximately 510% Sequential Revenue Growth from Q1 2026 and Significant Improvement in Operating Performance
GlobeNewsWire · 70 d ago
GL
SCIENTURE Announces Commercial Launch and Fulfillment of Initial Purchase Orders of REZENOPY™, the Highest Dose FDA-Approved Naloxone Nasal Spray
GlobeNewsWire · 72 d ago
End of the feed